radiotherapy bridging for axi-cel in large b-cell lymphoma
Published 4 years ago • 147 plays • Length 3:21Download video MP4
Download video MP3
Similar videos
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:20
axi-cel in patients with r/r lbcl in complete metabolic response
-
4:27
cytopenias after axi-cel in r/r large b-cell lymphoma: clinical implications
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
6:28
cytoquest™ cr ctc enrichment - rbc lysis
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
6:43
phase ii study of response-adapted ultra-low dose radiotherapy for b-cell lymphoma
-
1:11
insights into real-world outpatient administration of axi-cel and brexu-cel in r/r nhl
-
2:08
impact of bridging therapy on the outcomes of patients with r/r myeloma treated with ide-cel
-
2:30
impact of bridging therapy on the outcomes of patients with r/r myeloma treated with ide-cel
-
3:07
the role of bridging and timing in car-t
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
3:33
a novel composite endpoint of toxicity and pfs in patients with r/r fl treated with axi-cel
-
1:45
promising activity of ka2237 in r/r b-cell lymphoma
-
1:26
can we improve on r-chop for the frontline treatment of dlbcl?
-
1:22
safety and efficacy of cc-99282 in the treatment of r/r nhl
-
1:34
recent and upcoming data on axi-cel for patients with nhl
-
3:12
car-t for all: the impact of bridging therapy
-
2:25
does bridging therapy affect lymphoma car-t outcomes?